Maintenance immunotherapy in advanced urothelial cancer
Advanced urothelial carcinoma usually responds to platinum-based chemotherapy (CT), although overall survival (OS) and progression-free survival are typically short. Immunotherapy is a promising treatment strategy, but the first-line benefits in platinum-eligible patients are limited, and its combin...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Permanyer
2022-07-01
|
Series: | Gaceta Mexicana de Oncología |
Subjects: | |
Online Access: | https://www.gamo-smeo.com/frame_esp.php?id=323 |